Among the enrolled NSCLC patients, we confirmed PD-1–positive CD8+ T cells in peripheral blood and further classified them into PD-1high, PD-1low, and PD-1neg subsets by the expression level of PD-1 (Figure 2B). Here, CD8A is linked to non-small cell lung carcinoma.